<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2026.1761186</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>MexS mediated heteroresistance of <italic>Pseudomonas aeruginosa</italic> to ciprofloxacin</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Ma</surname> <given-names>Xiaodan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Chen</surname> <given-names>Yana</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/3303298/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Xiao</surname> <given-names>Chenlu</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1176074/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Congcong</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name><surname>Han</surname> <given-names>Lizhong</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &amp; editing</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Li</surname> <given-names>Chengxi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/885651/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ni</surname> <given-names>Jinjing</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2938335/overview"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Anhui Key Laboratory of Infection and Immunity, Bengbu Medical University, Bengbu</institution>, <city>Anhui</city>, <country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Biochemistry and Molecular Biology, Bengbu Medical University, Bengbu</institution>, <city>Anhui</city>, <country country="cn">China</country></aff>
<aff id="aff3"><label>3</label><institution>Division of Life Sciences and Medicine, Department of Pediatrics, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei</institution>, <city>Anhui</city>, <country country="cn">China</country></aff>
<aff id="aff4"><label>4</label><institution>Department of Laboratory Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine</institution>, <city>Shanghai</city>, <country country="cn">China</country></aff>
<aff id="aff5"><label>5</label><institution>Department of Clinical Microbiology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine</institution>, <city>Shanghai</city>, <country country="cn">China</country></aff>
<aff id="aff6"><label>6</label><institution>Laboratory of Bacterial Pathogenesis, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine</institution>, <city>Shanghai</city>, <country country="cn">China</country></aff>
<aff id="aff7"><label>7</label><institution>Department of Microbiology, Bengbu Medical University, Bengbu</institution>, <city>Anhui</city>, <country country="cn">China</country></aff>
<author-notes>
<corresp id="c001"><label>&#x002A;</label>Correspondence: Jinjing Ni, <email xlink:href="mailto:nijinjing45@163.com">nijinjing45@163.com</email></corresp>
<corresp id="c002">Chengxi Li, <email xlink:href="mailto:chengx-li@bbmu.edu.cn">chengx-li@bbmu.edu.cn</email></corresp>
<fn fn-type="equal" id="fn002"><label>&#x2020;</label><p>These authors share first authorship</p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-19">
<day>19</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>17</volume>
<elocation-id>1761186</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>14</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>01</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2026 Ma, Chen, Xiao, Li, Han, Li and Ni.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Ma, Chen, Xiao, Li, Han, Li and Ni</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-19">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Bacterial heteroresistance has been increasingly identified as an important phenomenon for many antibiotic/bacterium combinations. However the mechanisms underlying ciprofloxacin heteroresistance in <italic>P. aeruginosa</italic>, a key drug for treating this pathogen, remain poorly understood. In this study, 11 ciprofloxacin-heteroresistant <italic>P. aeruginosa</italic> isolates were identified by screening 226 clinical strains. Whole-genome sequencing (WGS) identified recurrent mutations within the <italic>mexS</italic> gene among these isolates. Crucially, CRISPR-Cas9-mediated deletion of <italic>mexS</italic> in the representative heteroresistant isolate (7318HR) abolished the heteroresistance phenotype, thereby confirming its functional necessity. Transcriptomic profiling following <italic>mexS</italic> deletion identified 532 differentially expressed genes involved in multiple biological processes, including phenazine biosynthesis, propanoate metabolism, bacterial secretion systems, and quorum sensing. Notably, genes associated with type IVb-tad pili were significantly downregulated. Consistent with this, the <italic>mexS</italic> mutant exhibited concurrent impairments in virulence-associated traits, including markedly reduced twitching motility (by approximately 38%) and polystyrene adhesion capacity (by approximately 50%) compared to the wild-type strain. These findings demonstrate that <italic>mexS</italic> is a key genetic determinant of ciprofloxacin heteroresistance in <italic>P. aeruginosa</italic> and concurrently modulates pilus-mediated virulence-associated functions.</p>
</abstract>
<kwd-group>
<kwd>ciprofloxacin heteroresistance</kwd>
<kwd>mexS</kwd>
<kwd><italic>P. aeruginosa</italic></kwd>
<kwd>pilus-mediated virulence-associated functions</kwd>
<kwd>twitching</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This work was supported by grants from the National Natural Science Foundation of China (81830068, 82272351, and 81772140, 31700121, 31900111, 81501733), the Key Research and Development Project of China (nos. 2024YFA1306800 and 2022YFA1304300). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="35"/>
<page-count count="12"/>
<word-count count="7316"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Antimicrobials, Resistance and Chemotherapy</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p><italic>Pseudomonas aeruginosa</italic> is an aerobic, gram-negative bacterium characterized by a single polar flagellum. It is a major opportunistic pathogen responsible for nosocomial infections (<xref ref-type="bibr" rid="B11">Holmes et al., 2021</xref>; <xref ref-type="bibr" rid="B17">Krell and Matilla, 2024</xref>) and causes substantial mortality annually, particularly in cases involving antibiotic-resistant strains (<xref ref-type="bibr" rid="B11">Holmes et al., 2021</xref>). Ubiquitous in the environment, <italic>P. aeruginosa</italic> exhibits intrinsic resistance mechanisms that allow it to evade most conventional antibiotics (<xref ref-type="bibr" rid="B25">Pang et al., 2019</xref>). Multidrug-resistant variants account for a considerable proportion of clinical isolates, significantly complicating treatment (<xref ref-type="bibr" rid="B4">Botelho et al., 2019</xref>; <xref ref-type="bibr" rid="B28">Qin et al., 2022</xref>). In recognition of its threat, the World Health Organization designated <italic>P. aeruginosa</italic> as a high-priority pathogen in 2024 (<xref ref-type="bibr" rid="B33">World Health Organization [WHO], 2024</xref>). Studies in recent years have reported the presence of heteroresistance in clinical settings that have been associated with treatment failure. Heteroresistance describes a phenotype in which a subpopulation of bacterial cells exhibits a higher level of antibiotic resistance than the predominant susceptible population (<xref ref-type="bibr" rid="B1">Andersson et al., 2019</xref>).</p>
<p>The current criteria for defining bacterial heteroresistance require that the minimum inhibitory concentration (MIC) of the resistant subpopulation be at least eight-fold higher than that of the susceptible main subpopulation, and that the frequency of this resistant subpopulation reaches or exceeds 10<sup>&#x2212;7</sup> (<xref ref-type="bibr" rid="B1">Andersson et al., 2019</xref>; <xref ref-type="bibr" rid="B23">Luo et al., 2024</xref>). These stringent criteria, coupled with the reliance of routine clinical microbiology laboratories on methods (such as standard broth microdilution or disk diffusion) that may not detect minority resistant subpopulations, contribute to the underdetection of heteroresistance in clinical practice. Identified mechanisms underlying heteroresistance include&#x2014;but are not limited to&#x2014;spontaneous tandem amplification of resistance genes (<xref ref-type="bibr" rid="B1">Andersson et al., 2019</xref>; <xref ref-type="bibr" rid="B7">Dewachter et al., 2019</xref>), upregulation of drug efflux pump genes and downregulation of porin proteins (<xref ref-type="bibr" rid="B10">He et al., 2018</xref>; <xref ref-type="bibr" rid="B35">Xu Y. et al., 2020</xref>), and the activity of two-component regulatory systems (<xref ref-type="bibr" rid="B8">Doijad et al., 2023</xref>; <xref ref-type="bibr" rid="B15">Kang et al., 2019</xref>). Additionally, essential genes involved in DNA repair, as well as quorum sensing genes <italic>lasI</italic> and <italic>rhlI</italic>, have also been implicated in this phenotype (<xref ref-type="bibr" rid="B19">Li et al., 2022</xref>; <xref ref-type="bibr" rid="B22">Lu et al., 2022</xref>).</p>
<p>Although heterogeneous resistance in <italic>P. aeruginosa</italic> to various antibiotics has been extensively studied (<xref ref-type="bibr" rid="B9">Egge et al., 2024</xref>; <xref ref-type="bibr" rid="B12">Howard-Anderson et al., 2022</xref>; <xref ref-type="bibr" rid="B13">Jia et al., 2020</xref>), its underlying mechanisms remain incompletely elucidated, particularly in the context of ciprofloxacin for <italic>P. aeruginosa</italic> infections. Furthermore, the specific prevalence and clinical impact of ciprofloxacin heteroresistance may be underestimated due to the aforementioned detection challenges. In this study, we identified 11 clinical isolates of <italic>P. aeruginosa</italic> exhibiting heteroresistance to ciprofloxacin. Utilizing high-throughput sequencing, we were screened for key genes involved in this phenotype and identified <italic>mexS</italic> as a critical determinant. The biological functions of <italic>mexS</italic> were further investigated to clarify its role in heteroresistance.</p>
</sec>
<sec id="S2" sec-type="results">
<title>Results</title>
<sec id="S2.SS1">
<title>Screening of ciprofloxacin heteroresistance isolating strains</title>
<p>A total of 226 <italic>P. aeruginosa</italic> isolates collected from sputum, alveolar lavage fluid, drainage fluid and midstream urine samples from 96 patients in Ruijin and Renji hospitals (Ethics statement: The study received ethical approval from the Ethics Committee of the Ruijin Hospital, Shanghai Jiao Tong University (No. 2023-79). Informed consent was obtained from all participants) were tested for heteroresistance. Most of these patients are critically ill, with a small number from patients with chronic infections such as COPD and bronchiectasis. Firstly, we evaluated 226 isolates for drug resistance to ciprofloxacin using the Clinical and Laboratory Standards Institute (CLSI) operational methods for antimicrobial susceptibility testing. Among these isolates, 26 (11.5%) were intermediate, 59 (26.11%) were resistant, and 141 (62.39%) were susceptible (<xref ref-type="fig" rid="F1">Figure 1A</xref>). We found some monoclonal colonies within the inhibition zones of some isolates (<xref ref-type="supplementary-material" rid="FS1">Supplementary Figure 1</xref>). In order to identify the potentially heteroresistant isolates, we conducted two rounds of screening by the disc diffusion method and identified 11 suspected isolates. For clarity, the primary clinical isolates exhibiting this phenotype are hereafter referred to as heteroresistant isolates (HR). We further validated the 11 candidate HR isolates by PAP testing. To obtain HR isolates that could generate stable resistant subpopulations (R), we further selected monoclones from the inhibitory region of antimicrobial susceptibility disk and tested them for ciprofloxacin resistance after 14 consecutive passages on antibiotic-free plates. Each passage involved transferring a 1:100 dilution of the culture to fresh medium and incubating for 12 h. The R subpopulations derived from these 11 HR isolates are indicated in <xref ref-type="fig" rid="F1">Figure 1B</xref>. The PAP curve indicated the frequency of the resistant subpopulation of PAO1 at 4-fold MIC has reached 10<sup>&#x2013;10</sup>, which was much lower than 10<sup>&#x2013;7</sup>, while the frequency of the 11 HR isolates at 8-fold MIC was still higher than 10<sup>&#x2013;7</sup> (<xref ref-type="fig" rid="F1">Figure 1C</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Detection of heteroresistance and drug sensitivity to ciprofloxacin in clinical isolates of <italic>Pseudomonas aeruginosa</italic>. <bold>(A)</bold> Statistical analysis of MIC test of 226 clinical isolates to ciprofloxacin. <bold>(B)</bold> Screening workflow and main results of heteroresistant isolates (HR). <bold>(C)</bold> PAP (population analysis profiling) of HR isolates.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-17-1761186-g001.tif">
<alt-text content-type="machine-generated">Panel A shows a pie chart illustrating antibiotic susceptibility among 226 bacterial isolates: 62.6 percent are sensitive, 26.0 percent resistant, and 11.5 percent intermediary. Panel B presents a flowchart of the experimental design: 226 isolates from ninety-six patients underwent disk diffusion, with eighteen isolates suspected of heteroresistance, followed by a second disk diffusion, PAP test, and seven-day passage to confirm eleven stable resistant isolates. Panel C displays a line graph with the frequency of antibiotic-resistant bacteria on the y-axis and increasing antibiotic concentration in multiples of minimum inhibitory concentration on the x-axis, showing decreased bacterial frequency in HR isolates as concentration increases.</alt-text>
</graphic>
</fig>
<p>To further determine whether the resistant strains isolated from the HR isolates still retained the heteroresistance characteristics, we also conducted a PAP test on the R subpopulations, and the results are shown in <xref ref-type="supplementary-material" rid="FS2">Supplementary Figure 2</xref>, where all the R subpopulations obtained by isolation from the HR isolates lost the heteroresistance features. Nevertheless, the MIC of ciprofloxacin was determined by R subpopulations and HR isolates, and it was found that the MIC of R subpopulations was generally more than 8-fold elevated compared to that of HR isolates, and the results are shown in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Susceptibilities of heteroresistant pseudomonas aeruginosa isolates (HR) and their derived resistant subpopulations (R).</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<th valign="top" align="left">HR Isolate</th>
<th valign="top" align="center">MIC (mg/L)</th>
<th valign="top" align="center">R subpopulation</th>
<th valign="top" align="center">MIC (mg/L)</th>
<th valign="top" align="center">MIC fold change (R/HR)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">30HR</td>
<td valign="top" align="center">0.5</td>
<td valign="top" align="center">30R</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">8</td>
</tr>
<tr>
<td valign="top" align="left">1595HR</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">1595R</td>
<td valign="top" align="center">64</td>
<td valign="top" align="center">8</td>
</tr>
<tr>
<td valign="top" align="left">6655HR</td>
<td valign="top" align="center">0.125</td>
<td valign="top" align="center">6655R</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">32</td>
</tr>
<tr>
<td valign="top" align="left">7314HR</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">7314R</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">16.7</td>
</tr>
<tr>
<td valign="top" align="left">7318HR</td>
<td valign="top" align="center">0.125</td>
<td valign="top" align="center">7318R</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">16</td>
</tr>
<tr>
<td valign="top" align="left">7500HR</td>
<td valign="top" align="center">0.125</td>
<td valign="top" align="center">7500R</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">16</td>
</tr>
<tr>
<td valign="top" align="left">7637HR</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">7637R</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">16.7</td>
</tr>
<tr>
<td valign="top" align="left">7755HR</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">7755R</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">16.7</td>
</tr>
<tr>
<td valign="top" align="left">7866HR</td>
<td valign="top" align="center">0.5</td>
<td valign="top" align="center">7866R</td>
<td valign="top" align="center">4</td>
<td valign="top" align="center">8</td>
</tr>
<tr>
<td valign="top" align="left">7895HR</td>
<td valign="top" align="center">0.06</td>
<td valign="top" align="center">7895R</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">33.3</td>
</tr>
<tr>
<td valign="top" align="left">A601HR</td>
<td valign="top" align="center">0.125</td>
<td valign="top" align="center">A601R</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">8</td>
</tr>
</tbody>
</table></table-wrap>
</sec>
<sec id="S2.SS2">
<title>Genome sequencing analysis of HR isolates and R subpopulations</title>
<p>Since the R subpopulations lost their heteroresistance relative to their parental HR isolates, we performed whole-genome sequencing of the 11 HR isolates and their corresponding subpopulations. Analysis of the genetic variants in the R subpopulations revealed that single nucleotide variants (SNVs) were the predominant type (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Notably, mutations in the <italic>mexS</italic> gene were identified in 8 of the 11 pairs, and mutations in <italic>gyrA</italic> were found in 2 pairs. Other genes, including <italic>csrA</italic>, <italic>fleQ</italic>, <italic>PA2632</italic>, <italic>PAKAK-02255</italic>, <italic>PAKAF-02812</italic>, <italic>rgdC</italic>, and <italic>vgrG</italic>, each harbored a mutation in a single isolate.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>The proportion of strains with genetic mutations between R isolates selected from HR isolates and their corresponding parental heteroresistant strains, along with the transcription levels of the efflux pump-associated genes <italic>mexE</italic> and <italic>mexS</italic>. <bold>(A)</bold> The number of strains with genetic mutations when comparing R strains with their corresponding HR strains. <bold>(B)</bold> RT-qPCR analysis of <italic>mexE</italic> gene expression in resistant subpopulations (R) carrying <italic>mexS</italic> mutations cultured in LB medium, with expression levels normalized to 1 relative to the corresponding heteroresistant isolates (HR). <bold>(C)</bold> RT-qPCR analysis of <italic>mexS</italic> gene expression in resistant subpopulations (R) carrying <italic>mexS</italic> mutations cultured in LB medium, with expression levels normalized to 1 relative to the corresponding heteroresistant isolates (HR). &#x002A;Represents <italic>p</italic> &#x2264; 0.05, &#x002A;&#x002A;represents <italic>p</italic> &#x2264; 0.01, &#x002A;&#x002A;&#x002A;represents <italic>p</italic> &#x2264; 0.001 indicating significant differences between the R subpopulations and the parental HR strains. RT- qPCR, real-time quantitative reverse transcription PCR.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-17-1761186-g002.tif">
<alt-text content-type="machine-generated">Three-panel scientific figure showing: (A) lollipop chart of samples with mutations in various genes, with most mutations in mexS and a total of eleven samples; (B) bar graph of mexE relative expression for clinical isolates, with higher expression and significance levels indicated; (C) bar graph of mexS relative expression for the same isolates, showing variable increases and significance denoted by asterisks.</alt-text>
</graphic>
</fig>
<p>Given the high prevalence of <italic>mexS</italic> mutations (8/11), we focused our subsequent analysis on this gene. Among these eight HR-R pairs, three R subpopulations (30R, 7550R, and 7637R) harbored deletions in <italic>mexS</italic>, with 30R and 7550R containing larger deletions of 11 and 15 nucleotides, respectively. One R subpopulation (6655R) contained a single-nucleotide insertion. These insertion/deletion events all resulted in frameshift mutations. The remaining four R subpopulations (7318R, 7755R, 7860R, and 7895R) contained single-nucleotide substitutions, leading to either missense mutations or a premature stop codon (nonsense mutation). The specific <italic>mexS</italic> mutations identified in the R subpopulations relative to their paired HR isolates are detailed in <xref ref-type="table" rid="T2">Table 2</xref>, which provides the nucleotide positions, sequence changes, and predicted amino acid consequences. The MIC of ciprofloxacin in the R strains with the <italic>mexS</italic> mutation and their corresponding HR isolates was examined, and it was found that all R subpopulations exhibited a significant increase in MIC relative to the HR isolates, with an 8&#x2013;33.33-fold increase in MIC (<xref ref-type="table" rid="T1">Table 1</xref>). It has been demonstrated that the inactivation of MexS can result in the overexpression of the drug efflux pump <italic>mexEF-oprN</italic> (<xref ref-type="bibr" rid="B34">Xu C. et al., 2020</xref>), which in turn leads to an increased resistance to antibiotics. The transcript levels of <italic>mexS</italic> and the efflux pump genes <italic>mexE</italic> were examined by RT-qPCR between the eight R isolates with <italic>mexS</italic> mutations and their parents. The results demonstrated that the relative transcript levels of <italic>mexE</italic> were significantly higher in the R subpopulations than those of the HR isolates (<xref ref-type="fig" rid="F2">Figure 2B</xref>). A similar trend was observed for <italic>mexS</italic> (<xref ref-type="fig" rid="F2">Figure 2C</xref>).</p>
<table-wrap position="float" id="T2">
<label>TABLE 2</label>
<caption><p><italic>mexS</italic> gene mutations identified in heteroresistant (HR) <italic>Pseudomonas aeruginosa</italic> isolates and their derived resistant (R) subpopulations.</p></caption>
<table cellspacing="5" cellpadding="5" frame="box" rules="all">
<thead>
<tr>
<th valign="top" align="left">Strain (ID)</th>
<th valign="top" align="center">Genotype (HR vs. R)</th>
<th valign="top" align="center">Contig</th>
<th valign="top" align="center">Nucleotid e position</th>
<th valign="top" align="center">Reference</th>
<th valign="top" align="center">Alter</th>
<th valign="top" align="center">Amino acid change</th>
<th valign="top" align="center">Mutation type</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">30</td>
<td valign="top" align="center">30HR/30R</td>
<td valign="top" align="center">NODE_10</td>
<td valign="top" align="center">29,007</td>
<td valign="top" align="center">CACCCGGCCACG</td>
<td valign="top" align="center">C</td>
<td valign="top" align="center">p. (AA330-333fs)</td>
<td valign="top" align="center">Frameshift</td>
</tr>
<tr>
<td valign="top" align="left">6655</td>
<td valign="top" align="center">6655HR/6655R</td>
<td valign="top" align="center">NODE_1</td>
<td valign="top" align="center">30,008</td>
<td valign="top" align="center">G</td>
<td valign="top" align="center">GA</td>
<td valign="top" align="center">p. (AA118fs)</td>
<td valign="top" align="center">Frameshift</td>
</tr>
<tr>
<td valign="top" align="left">7318</td>
<td valign="top" align="center">7318HR/7318R</td>
<td valign="top" align="center">NODE_1</td>
<td valign="top" align="center">904,371</td>
<td valign="top" align="center">T</td>
<td valign="top" align="center">C</td>
<td valign="top" align="center">p. (Phe259Ser)</td>
<td valign="top" align="center">Missense</td>
</tr>
<tr>
<td valign="top" align="left">7550</td>
<td valign="top" align="center">7550HR/7550R</td>
<td valign="top" align="center">NODE_2</td>
<td valign="top" align="center">1,700</td>
<td valign="top" align="center">GCCGACTCGTTGCCGC</td>
<td valign="top" align="center">G</td>
<td valign="top" align="center">p. (AA225-247fs)</td>
<td valign="top" align="center">Frameshift</td>
</tr>
<tr>
<td valign="top" align="left">7637</td>
<td valign="top" align="center">7637HR/7637R</td>
<td valign="top" align="center">NODE_18</td>
<td valign="top" align="center">26,539</td>
<td valign="top" align="center">CG</td>
<td valign="top" align="center">C</td>
<td valign="top" align="center">p. (AA142fs)</td>
<td valign="top" align="center">Frameshift</td>
</tr>
<tr>
<td valign="top" align="left">7755</td>
<td valign="top" align="center">7755HR/7755R</td>
<td valign="top" align="center">NODE_7</td>
<td valign="top" align="center">1,239</td>
<td valign="top" align="center">C</td>
<td valign="top" align="center">A</td>
<td valign="top" align="center">p. (Trp42Leu)</td>
<td valign="top" align="center">Missense</td>
</tr>
<tr>
<td valign="top" align="left">7860</td>
<td valign="top" align="center">7860HR/7860R</td>
<td valign="top" align="center">NODE_2</td>
<td valign="top" align="center">925</td>
<td valign="top" align="center">G</td>
<td valign="top" align="center">A</td>
<td valign="top" align="center">p. (Gln147stop)</td>
<td valign="top" align="center">Nonsense</td>
</tr>
<tr>
<td valign="top" align="left">7895</td>
<td valign="top" align="center">7895HR/7895R</td>
<td valign="top" align="center">NODE_1</td>
<td valign="top" align="center">2,002,359</td>
<td valign="top" align="center">T</td>
<td valign="top" align="center">C</td>
<td valign="top" align="center">p. (Leu46Pro)</td>
<td valign="top" align="center">Missense</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>The table lists mutations identified by comparing the genome sequences of the heteroresistant parental isolate (HR) with that of its derived stable resistant subpopulation (R) for each strain. &#x201C;Nucleotide Position&#x201D; is based on the assembled contig of the HR isolate. &#x201C;Amino Acid Change&#x201D; is predicted from the mutation in the R subpopulation relative to the HR sequence.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="S2.SS3">
<title>Characterization of the genetic mechanism of heteroresistance to ciprofloxacin</title>
<p>To further elucidate the correlation between <italic>mexS</italic> and heteroresistance, the sequence of MexS in HR isolates was initially examined. It was ascertained that all HR isolates exhibited an identical MexS sequence. A comparison of the MexS sequence with that of the laboratory strain PAO1 revealed a single amino acid difference, namely, the 249th amino acid, which was asparagine (N) for HR isolates and aspartic acid (D) for PAO1 (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Subsequently, we employed the CRISPR/Cas9 system to induce a knockout of the <italic>mexS</italic> gene in the 7318HR strain. By measuring the growth curves of strains 7318HR-&#x0394;<italic>mexS</italic> and 7318HR in LB medium without antibiotics, it was found that the stationary-phase biomass of 7318HR-&#x0394;<italic>mexS</italic> was approximately 20% lower than that of 7318HR (<xref ref-type="fig" rid="F3">Figure 3B</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>Sequence comparison of MexS among strains 7318HR, 7318R, and PAO1, as well as the impact of <italic>mexS</italic> gene deletion on the growth of strain 7318HR and its resistance to ciprofloxacin. <bold>(A)</bold> Sequence comparison of MexS among strains 7318HR, 7318R, and PAO1. <bold>(B)</bold> The growth curves of isolate 7318HR and its deletion mutant in LB medium at 37&#x00B0;C. <bold>(C)</bold> Susceptibility results of isolate 7318HR and its deletion mutant to ciprofloxacin on MH agar plates. <bold>(D)</bold> PAP curve of isolate 7318HR, 7318HR-&#x0394;<italic>mexS</italic>, and 7318HR-&#x0394;<italic>mexS</italic>-p<italic>mexS</italic>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-17-1761186-g003.tif">
<alt-text content-type="machine-generated">Panel A shows a sequence alignment of three protein variants, highlighting differences with red letters at residues 249 and 259. Panel B is a line graph displaying bacterial growth (OD600) over 13 hours, comparing 7318HR and 7318HR-&#x0394;mexS strains. Panel C presents two circular agar diffusion assay images with central antibiotic disks, with the inhibition zone appearing larger for 7318HR compared to 7318HR-&#x0394;mexS. Panel D features a line graph showing the frequency of antibiotic-resistant bacteria versus antibiotic concentration, comparing four bacterial strains indicated by different colored lines.</alt-text>
</graphic>
</fig>
<p>The results demonstrated that the <italic>mexS</italic>-deficient strains exhibited a loss of the heteroresistance phenotype to ciprofloxacin (<xref ref-type="fig" rid="F3">Figure 3C</xref>). This was evidenced by the absence of single colonies in the zone of inhibition and the incompatibility of the PAP test with heteroresistance, as illustrated in <xref ref-type="fig" rid="F3">Figure 3D</xref>. In parallel, the complementation of <italic>mexS</italic>-deficient strains by plasmids carrying <italic>mexS</italic> sequences from 7318HR isolates resulted in the reversion of heteroresistance phenotypes, thereby confirming the association of the <italic>mexS</italic> gene with heteroresistance to ciprofloxacin in <italic>P. aeruginosa</italic>. This also illustrates the intricacy of the heteroresistance mechanism to ciprofloxacin in <italic>P. aeruginosa</italic>, which does not facilitate the transformation of non-heteroresistant strains into heteroresistant strains through a single expression of the <italic>mexS</italic> gene.</p>
</sec>
<sec id="S2.SS4">
<title>RNA sequencing analysis of <italic>mexS</italic> deletion mutants</title>
<p>Given the <italic>mexS</italic> mutant phenotypes observed across all HR isolates and the suitability of this strain for subsequent studies, we selected 7318HR to focus our investigations. In order to gain further insight into the function of the <italic>mexS</italic> gene in <italic>P. aeruginosa</italic>, we conducted a transcriptome sequencing analysis of three strains: 7318HR, 7318HR-&#x0394;<italic>mexS</italic>, and 7318R. This analysis was performed under culture conditions without antibiotics, and the number of genes whose expression was detected in the transcriptomes of all three strains exceeded 6,000.</p>
<p>A differential expression analysis of the transcriptomes of the three strains revealed that, in comparison to 7318HR, strains 7318R and 7318HR-&#x0394;<italic>mexS</italic> exhibited a higher number of differentially expressed genes. The number of differentially expressed genes was 532 and 487, respectively, whereas strains 7318R and 7318HR-&#x0394;<italic>mexS</italic> exhibited differential expression of only 183 genes. The Venn plots of the number of differentially expressed genes (DEGs) for the three strains are presented in <xref ref-type="fig" rid="F4">Figure 4A</xref>. The data indicate that the DEGs were primarily concentrated in the two analyzed groups, 7318R-vs.-7318HR and 7318HR-&#x0394;<italic>mexS</italic>-vs.-7318HR. In contrast, the expression of the genes in the 7318R-vs.-7318HR-&#x0394;<italic>mexS</italic> group exhibited a relatively limited range of variation. The 7318R and 7318HR-&#x0394;<italic>mexS</italic> strains exhibited a relatively close transcriptional profile (<xref ref-type="supplementary-material" rid="FS3">Supplementary Figure 3</xref>), suggesting that the majority of genes exhibiting altered transcriptional levels in 7318R were associated with the occurrence of a mutation in <italic>mexS</italic>.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>Transcriptome analysis of isolate 7318HR, 7318R, and 7318HR-&#x0394;<italic>mexS</italic>, and qPCR quantification of efflux pump genes and flagellar assembly genes. <bold>(A)</bold> Venn diagram of differentially expressed genes (DEGs) in transcriptomes of isolate 7318HR, 7318R, and 7318HR-&#x0394;<italic>mexS</italic>. Each circle contains the set of differentially expressed genes (DEGs) derived from the comparison of that strain against the other two. The &#x201C;7318HR&#x201D; circle contains DEGs from the comparison of 7318HR against 7318HR-&#x0394;<italic>mexS</italic>. The &#x201C;7318R&#x201D; circle contains DEGs from the comparison of 7318R against 7318HR. The &#x201C;7318HR-&#x0394;<italic>mexS</italic>&#x201D; circle contains DEGs from the comparison of 7318HR-&#x0394;<italic>mexS</italic> against 7318R. <bold>(B)</bold> KEGG pathway enrichment analysis of differentially expressed genes between 7318HR and 7318HR-&#x0394;<italic>mexS</italic>. <bold>(C)</bold> RT-qPCR analysis comparing <italic>mexE</italic> and <italic>mexT</italic> gene expression between 7318HR and 7318HR-&#x0394;<italic>mexS</italic> cultured in LB medium, normalized using expression levels in 738HR. Positive values after normalization indicate upregulation of the respective gene in the mutant strain relative to 7318HR. <bold>(D)</bold> RT-qPCR analysis was performed to compare expression levels of flagellar synthesis genes (<italic>flp</italic>, <italic>cpaB</italic>, <italic>pprB</italic>, <italic>pprA</italic>, <italic>tadB</italic>) and the virulence gene <italic>exoS</italic> in isolate 7318HR and 7318HR-&#x0394;<italic>mexS</italic> cultured in LB broth. Data were normalized against isolate 738HR, where negative values indicate downregulation of the respective gene in the &#x0394;<italic>mexS</italic> mutant relative to 7318HR. &#x002A; Represents <italic>p</italic> &#x2264; 0.05, &#x002A;&#x002A;represents <italic>p</italic> &#x2264; 0.01, &#x002A;&#x002A;&#x002A;represents <italic>p</italic> &#x2264; 0.001 indicating significant differences between the R subpopulations and the parental HR strains. RT- qPCR, real-time quantitative reverse transcription PCR.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-17-1761186-g004.tif">
<alt-text content-type="machine-generated">Panel A shows a Venn diagram comparing three groups, 7318HR, 7318HR-&#x0394;mexS, and 7318R, with overlap counts labeled in each area. Panel B presents a bubble plot showing enriched pathways such as phenazine biosynthesis, quorum sensing, and others based on z-score and -log10 adjusted p-value, with bubble size indicating gene number. Panel C provides a bar graph with error bars depicting relative expression of mexE and mexT, showing significantly increased expression for both. Panel D displays a bar graph with error bars showing reduced relative expression for flp, cpaB, pprB, pprA, tadB, and exoS, with statistical significance indicated by asterisks.</alt-text>
</graphic>
</fig>
<p>The DEGs in 7318HR-&#x0394;<italic>mexS</italic>-vs.-7318HR were analyzed in order to identify the pathways that were most significantly enriched by KEGG database. The top five pathways identified were Phenazine biosynthesis, Propanoate metabolism, Bacterial secretion system, Quorum sensing, and Sulfur metabolism. In addition, deletion of <italic>mexS</italic> also affected energy metabolism and the two-component system of <italic>P. aeruginosa</italic>, as shown in <xref ref-type="fig" rid="F4">Figure 4B</xref>. In the bacterial secretion system-enriched pathway, we observed that deletion of <italic>mexS</italic> caused a down-regulation of transcript levels of type III secretion system (T3SS)- and type VI secretion system (T6SS)-related genes, suggesting that <italic>mexS</italic> also plays an important role in infection, colonization and virulence of <italic>P. aeruginosa</italic>.</p>
<p>Transcriptional analysis via RT-qPCR revealed significant upregulation of multidrug efflux genes (<italic>mexE</italic>, <italic>mexT</italic>) and downregulation of flagellar biosynthesis associated genes in <italic>P. aeruginosa</italic> 7318HR<italic>-&#x0394;mexS</italic> mutant compared to 7318HR strain. Specifically, <italic>mexE</italic> and <italic>mexT</italic> exhibited 183- and 31-fold increases, respectively (<xref ref-type="fig" rid="F4">Figure 4C</xref>), while flagellum biogenesis genes displayed 32&#x2013;87% reductions (<xref ref-type="fig" rid="F4">Figure 4D</xref>), consistent with RNA-seq expression profiles.</p>
</sec>
<sec id="S2.SS5">
<title>Effect of <italic>mexS</italic> on type IVb-tad pili assembly and associated phenotypes</title>
<p>Transcriptome analysis revealed that deletion of the <italic>mexS</italic> gene led to significant downregulation of genes encoding type IVb-tad pili. This finding was confirmed by RT-qPCR analysis of key pilus-related genes, including <italic>flp</italic>, <italic>cpaB</italic>, <italic>pprB</italic>, <italic>pprA</italic>, and <italic>tadB</italic> (<xref ref-type="fig" rid="F4">Figure 4D</xref>).</p>
<p>Given the established role of type IVb-tad pili in twitching motility and surface adhesion in <italic>P. aeruginosa</italic>, we hypothesized that <italic>mexS</italic> deletion would impair these functions. Phenotypic assays supported this hypothesis: the &#x0394;<italic>mexS</italic> mutant exhibited a significant reduction in both polystyrene adhesion capacity (approximately 50% decrease) (<xref ref-type="fig" rid="F5">Figures 5A</xref>) and twitching motility (approximately 38% decrease in zone diameter) (<xref ref-type="fig" rid="F5">Figures 5B,C</xref>) compared to the wild-type strain 7318HR. Importantly, these defects were fully restored upon genetic complementation with a plasmid carrying <italic>mexS</italic> (<xref ref-type="fig" rid="F5">Figures 5A&#x2013;C</xref>), confirming the specific role of <italic>mexS</italic> in regulating these pilus-mediated traits.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p>Impact of <italic>mexS</italic> deletion on <italic>Pseudomonas aeruginosa</italic> surface attachment to inert substrates and twitching motility. <bold>(A)</bold> Surface attachment assessment of isolate 7318HR, 7318R, 7318HR-&#x0394;<italic>mexS</italic>, 7318HR-&#x0394;<italic>mexS</italic>-p<italic>mexS</italic> and 7318HR-&#x0394;<italic>mexS</italic>-pEV on abiotic surfaces. LB medium was added to sterile 24-well polystyrene plates. Overnight bacterial cultures were diluted 1:100 into the plates, followed by static incubation at 37&#x00B0;C overnight. After aspirating the culture, 1% (w/v) crystal violet solution was added for 5 min staining. The plates were decolorized with 95% ethanol, washed, and finally added in 600 &#x03BC;L ultrapure water for OD<sub>570</sub> measurement. The data for each isolate is derived from three independent biological replicate experiments. &#x002A;&#x002A;&#x002A;&#x002A;<italic>p</italic> &#x003C; 0.0001, &#x002A;&#x002A;&#x002A;<italic>p</italic> &#x003C; 0.001, ns, not significant, two-tailed <italic>t</italic>-test. <bold>(B)</bold> Assessment of twitching motility capability for strains 7318HR, 7318R, 7318HR-&#x0394;<italic>mexS</italic>, 7318HR-&#x0394;<italic>mexS</italic>-p<italic>mexS</italic>, and 7318HR-&#x0394;<italic>mexS</italic>-pEV on LB agar plates. Single colonies of each strain were stab-inoculated into 3-mm-thick 1% LB agar plates. After 16-h incubation at 37&#x00B0;C, plates were stained with 1% (w/v) crystal violet. Following removal of unbound dye by washing, diameters of twitching motility zones were measured. The data for each isolate is derived from three independent biological replicate experiments. &#x002A;&#x002A;<italic>p</italic> &#x003C; 0.01, &#x002A;<italic>p</italic> &#x003C; 0.05, ns, not significant, two-tailed <italic>t</italic>-test. <bold>(C)</bold> Crystal violet staining results of twitching motility zones for strains 7318HR, 7318R, 7318HR-&#x0394;<italic>mexS</italic>, 7318HR-&#x0394;<italic>mexS</italic>-p<italic>mexS</italic>, and 7318HR-&#x0394;<italic>mexS</italic>-pEV on LB agar plates. Staining procedure was identical to that described for panel <bold>(B)</bold>.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-17-1761186-g005.tif">
<alt-text content-type="machine-generated">Panel A shows a bar graph comparing OD570nm values for five bacterial strains with statistical significance indicated by asterisks and error bars; Panel B presents a bar graph of twitching zone diameters for the same strains with comparisons marked similarly; Panel C displays four circular purple-stained bacterial twitching motility zones on agar plates, each aligned with a ruler showing measurements in centimeters, corresponding to the strains labeled below each image.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="S3" sec-type="discussion">
<title>Discussion</title>
<sec id="S3.SS1">
<title>Clinical resistance prevalence and heteroresistance identification</title>
<p>A total of 226 <italic>P. aeruginosa</italic> strains isolated from 96 patients at Ruijin and Renji hospitals were analyzed for ciprofloxacin susceptibility. Among these, 59 strains (26.11%) exhibited resistance, indicating a notably high prevalence of clinical resistance. Further screening via disc diffusion and population profiling identified 11 isolates showing heteroresistance to ciprofloxacin.</p>
</sec>
<sec id="S3.SS2">
<title><italic>mexS</italic> as a key genetic determinant of heteroresistance in strain 7318HR</title>
<p>Whole-genome sequencing of heteroresistant isolates and their stably resistant counterparts revealed that mutations in the <italic>mexS</italic> gene underlie the heteroresistant phenotype to ciprofloxacin. Of particular note, in the representative model strain 7318HR, <italic>mexS</italic> is annotated as a putative quinone oxidoreductase. Previous studies indicate that inactivating mutations in <italic>mexS</italic> can activate the <italic>mexEF</italic>-<italic>oprN</italic> operon via the transcriptional regulator MexT (<xref ref-type="bibr" rid="B31">Sobel et al., 2005</xref>; <xref ref-type="bibr" rid="B32">Wang et al., 2024</xref>), resulting in efflux pump overexpression and enhanced drug resistance. Additionally, MexS has been shown to suppress the expression of T3SS-related genes in a MexT-independent manner (<xref ref-type="bibr" rid="B14">Jin et al., 2011</xref>). Sequence analysis revealed notable diversity at amino acid position 249 of MexS: it is asparagine (N) in strains PAK and PA14, and aspartic acid (D) in PAO1. All 11 heteroresistant isolates in this study carried MexS-N249, which represses MexT transcriptional activity, whereas MexS-D249 does not. In contrast, MexS-D249 inhibits T3SS independently of MexT, while MexS-N249 lacks this ability (<xref ref-type="bibr" rid="B14">Jin et al., 2011</xref>; <xref ref-type="bibr" rid="B31">Sobel et al., 2005</xref>). The specific genetic and phenotypic analyses that follow focus on elucidating the role of <italic>mexS</italic> within the context of strain 7318HR.</p>
</sec>
<sec id="S3.SS3">
<title>Transcriptomic and phenotypic consequences of mexS deletion in 7318HR</title>
<p>Transcriptome analysis comparing the <italic>mexS</italic>-deficient mutant (7318HR-&#x0394;<italic>mexS</italic>) with the wild-type (7318HR) strain showed that <italic>mexS</italic> deletion led to downregulation of T3SS and T6SS-associated genes in this strain. KEGG pathway enrichment analysis highlighted five significantly affected pathways: phenazine biosynthesis, propanoate metabolism, bacterial secretion system, quorum sensing, and sulfur metabolism. Except for propanoate metabolism, these pathways were generally downregulated. Moreover, <italic>mexS</italic> deletion influenced the expression of genes involved in energy metabolism, two-component systems, and type IV tad pili (<xref ref-type="fig" rid="F5">Figure 5B</xref>). Although the number of differentially expressed genes was limited, their impact on metabolic synthesis in 7318HR was considerable. Phenotypic assays further demonstrated that <italic>mexS</italic> deletion 7318HR markedly impaired both twitching motility and surface attachment capability in this genetic background.</p>
<p>The transcriptomic changes observed upon <italic>mexS</italic> deletion are extensive, implicating diverse cellular processes. It is important to distinguish between the potential direct regulatory roles of MexS and the indirect, compensatory effects arising from global physiological rewiring. The strong downregulation of type III and type VI secretion system (T3SS/T6SS) genes aligns with previous reports of MexS influencing these pathways, potentially through mechanisms independent of its canonical regulator MexT (<xref ref-type="bibr" rid="B14">Jin et al., 2011</xref>). This suggests a more direct or proximal role for MexS in modulating virulence-associated secretion. Conversely, the broader alterations in metabolic pathways (e.g., phenazine biosynthesis, propanoate and sulfur metabolism) and two-component systems likely represent secondary, indirect consequences of the primary regulatory disruption. These changes may reflect the cell&#x2019;s adaptive response to the metabolic perturbation caused by <italic>mexS</italic> loss and the consequent activation of the <italic>mexEF-oprN</italic> efflux pump, which is energetically costly. While our data robustly map the transcriptional landscape resulting from <italic>mexS</italic> deletion, definitive assignment of direct targets requires future complementary approaches, such as chromatin immunoprecipitation sequencing (ChIP-seq) for any identified DNA-binding regulators in this cascade or kinetic transcriptomics following <italic>mexS</italic> repression.</p>
<p>Clinical implications and study limitations in clinical practice, MIC is a commonly utilized method for assessing the susceptibility of pathogenic bacteria to a specific antibiotic (<xref ref-type="bibr" rid="B24">Nicoloff et al., 2019</xref>). The presence of heteroresistance strains is frequently misidentified as that of sensitive strains under conditions of low antibiotic concentrations. This results in the administration of antibiotic treatment that not only fails to cure the infection but also facilitates the screening of drug-resistant mutant strains (<xref ref-type="bibr" rid="B13">Jia et al., 2020</xref>). Consequently, the use of MIC data as the sole criterion for determining bacterial susceptibility to antibiotics presents a significant challenge. Therefore, the resolution of the heteroresistance mechanism of <italic>P. aeruginosa</italic> is of paramount clinical importance.</p>
<p>Collectively, our findings in the model strain 7318HR establish that inactivation of <italic>mexS</italic> is a critical factor underlying the ciprofloxacin heteroresistance phenotype observed in this clinical isolate. Nevertheless, several limitations should be noted. First, our detailed mechanistic investigation&#x2014;including transcriptomics, CRISPR deletion, and in-depth phenotypic assays&#x2014;was conducted primarily in a single, representative heteroresistant isolate, 7318HR. While this allows for a deep and controlled analysis within this strain, it necessarily limits the generalizability of the <italic>mexS</italic>-dependent mechanism to other clinical HR isolates without further validation. Second, even within strain 7318HR, the precise mechanistic link between <italic>mexS</italic> inactivation and the heteroresistance phenotype remains to be fully disentangled. The concomitant upregulation of the <italic>mexEF-oprN</italic> efflux pump suggests its involvement; however, whether the observed heteroresistance is solely attributable to efflux activation or stems from broader regulatory rewiring orchestrated by <italic>mexS</italic> warrants further investigation. Future studies employing efflux pump inhibitors and isogenic mutants lacking both <italic>mexS</italic> and <italic>mexEF-oprN</italic> will be crucial to delineate their individual contributions and to clarify if the mechanism underlying heteroresistance in this context is distinct from that of stable high-level resistance. Finally, given that heteroresistance is inherently a multifaceted trait, the potential synergistic effects between <italic>mexS</italic> and other resistance mechanisms, such as efflux pump overexpression or adaptive mutations in two-component regulatory systems, remain an essential avenue for future inquiry, particularly across a broader collection of clinical isolates.</p>
</sec>
</sec>
<sec id="S4" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="S4.SS1">
<title>Strain activation and culture</title>
<p>A culture of <italic>P. aeruginosa</italic>, stored at &#x2212;80&#x00B0;C, was prepared by streaking on lysogenic broth (LB) solidified with 1.5% agar and incubated at 37&#x00B0;C for 24 h. A single clone was picked and inoculated into 5 mL of LB liquid medium and incubated at 37&#x00B0;C with agitation at 250 rpm for 24 h. This bacterial culture was then used for subsequent experiments. Unless otherwise stated, LB medium was used throughout this study, and cultures were incubated at 37&#x00B0;C with shaking at 250 rpm.</p>
</sec>
<sec id="S4.SS2">
<title>Disk-diffusion method</title>
<p>The disc diffusion assay was performed according to the protocol described in reference (<xref ref-type="bibr" rid="B30">Sherman et al., 2019</xref>). In brief, strains were activated on Mueller-Hinton (MH) medium. All other conditions and procedures were as described above. A sterile cotton swab dipped into the activated bacterial suspension and used to spread the suspension evenly on the MH solid medium. A sterile round paper disc containing 5 mg of ciprofloxacin was placed in the center of the solid medium. The incubator was set to 37&#x00B0;C for 48 h. The diameter of the inhibition zone was measured, and if distinct colonies were observed within the inhibition zone, the strain was preliminarily identified as exhibiting heteroresistance to ciprofloxacin.</p>
</sec>
<sec id="S4.SS3">
<title>Population analysis profile test</title>
<p>The population analysis profile test was performed according to the methodology detailed in reference (<xref ref-type="bibr" rid="B30">Sherman et al., 2019</xref>). In brief, solid medium containing ciprofloxacin was prepared at concentrations corresponding to 0.5, 1, 2, 4, 8, and 16 times the minimum inhibitory concentration (MIC). The activated strains underwent serial 10-fold dilution to achieve gradients from 10<sup>0</sup> to 10<sup>&#x2013;7</sup>. Aliquots (100 &#x03BC;L) of each dilution were plated onto the antibiotic-containing media and incubated at 37&#x00B0;C for 48 h. Technical triplicates were performed for each condition. Post-incubation, colony enumeration was conducted, with mean colony counts calculated and visualized using GraphPad software.</p>
</sec>
<sec id="S4.SS4">
<title>Determination of ciprofloxacin MIC</title>
<p>The minimum inhibitory concentration (MIC) determination was performed according to the protocol detailed in reference (<xref ref-type="bibr" rid="B30">Sherman et al., 2019</xref>). In brief, a ciprofloxacin solution was diluted with Mueller-Hinton (MH) liquid medium to a final concentration of 128 &#x03BC;g/mL. This solution was then sequentially two-fold dilutions to generate a gradient of antibiotic concentrations. Aliquots (100 &#x03BC;L) of each concentration were dispensed into sterile 96-well plates, with the final well of each row containing antibiotic-free MH medium as a negative control. The activated bacterial cultures were adjusted to an optical density at 600 nm (OD<sub>600</sub>) of 1.0 using MH liquid medium, followed by a 1,000-fold dilution. One hundred microliters of the diluted bacterial suspension were inoculated into the antibiotic-containing wells. After overnight incubation at 37&#x00B0;C, the OD<sub>600</sub> value of each well was measured via a microplate reader. The MIC was defined as the lowest antibiotic concentration at which bacterial growth matched the control well.</p>
</sec>
<sec id="S4.SS5">
<title>Heteroresistance stability assay</title>
<p>A monoclonal colony of the heteroresistant isolate in the vicinity of the small drug-containing paper disk in the disk diffusion assay (designated R1) was selected and subjected to serial passage on antibiotic-free LB plates. The strain was passaged twice daily (approximately every 12 h) for 7 days, with each passage involving the transfer of a 1:100 dilution of the culture to fresh antibiotic-free medium (resulting in a total of 14 passages and yielding R14). MICs of R1 and R14 were evaluated. In the event of no notable discrepancy, R14 was designated as the stable resistant subpopulation (R), while its parental strain was identified as the stable heteroresistant isolates (HR).</p>
</sec>
<sec id="S4.SS6">
<title>Genome and transcriptome sequencing and analysis</title>
<sec id="S4.SS6.SSS1">
<title>Genome sequencing and mutation analysis</title>
<p>The activated bacterial suspension were transferred to fresh 5 mL LB liquid medium at a dilution of 1:100 and incubated at 37&#x00B0;C until the OD<sub>600</sub> reached 1.0. At this point, the bacteria were collected by centrifugation. Bacterial genomic DNA was extracted using the Bacterial Genome Extraction Kit (TianGen, DP302-02). Using the Illumina platform and employing a paired-end sequencing strategy, the obtained raw data was filtered and genome sequences was assembled using the SPAdes software (<xref ref-type="bibr" rid="B27">Prjibelski et al., 2020</xref>). The Prokka software (<xref ref-type="bibr" rid="B29">Seemann, 2014</xref>) is employed for the purpose of predicting the gene set. Subsequently, we employed the BWA software (<xref ref-type="bibr" rid="B18">Li, 2013</xref>) for the comparison of reads from the second-generation sequencing of R strains with their counterparts on the HR genome. Finally, we employed the GATK software (<xref ref-type="bibr" rid="B26">Poplin et al., 2017</xref>) to identify the mutation sites between them.</p>
</sec>
<sec id="S4.SS6.SSS2">
<title>RNA sequencing and transcriptomic analysis</title>
<p>For transcriptome analysis, biological triplicates (<italic>n</italic> = 3) of both the wild-type strain 7318HR and its isogenic &#x0394;<italic>mexS</italic> mutant were processed independently. The activated bacterial suspension was transferred into fresh LB medium at a dilution of 1:100 and cultured until the OD600 reached a value between 1.0 and 1.5. Subsequently, 3 mL of the bacterial suspension was collected, and the extraction of total RNA from different strains was performed using the Bacterial RNA Extraction Kit (TianGen, DP430). RNA integrity was verified using an Agilent 2100 Bioanalyzer (RIN &#x003E; 8.0).</p>
<p>The analysis workflow was as follows:</p>
<list list-type="order">
<list-item>
<p>Raw sequencing reads were subjected to quality control using FastQC (v0.11.9) and trimmed for adapter sequences and low-quality bases using Trimmomatic (v0.39) (<xref ref-type="bibr" rid="B3">Bolger et al., 2014</xref>).</p>
</list-item>
<list-item>
<p>The cleaned reads were then mapped to the reference genome of strain 7318HR using HISAT2 (v2.2.1) (<xref ref-type="bibr" rid="B16">Kim et al., 2015</xref>).</p>
</list-item>
<list-item>
<p>Read counts for each annotated gene were generated using featureCounts (subread package v2.0.3) (<xref ref-type="bibr" rid="B20">Liao et al., 2014</xref>).</p>
</list-item>
<list-item>
<p>Differential gene expression analysis was performed using the R package DESeq2 (v1.34.0) (<xref ref-type="bibr" rid="B21">Love et al., 2014</xref>). The DESeq2 model internally normalized read counts using the median-of-ratios method. No batch effect correction was applied as all samples were processed in a single batch. The criteria for identifying differentially expressed genes (DEGs) were: |log2 (fold change) | &#x2265; 1 and an adjusted <italic>p</italic>-value (Benjamini-Hochberg method) &#x2264; 0.05.</p>
</list-item>
</list>
<p>The raw RNA-seq sequencing data have been deposited in the China National Center for Bioinformation (CNCB) under BioProject accession number <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="PRJCA055673">PRJCA055673</ext-link> (GSA: CRA037173, CRA037172).</p>
</sec>
</sec>
<sec id="S4.SS7">
<title>Construction of mutants</title>
<p>All genes knockout mutants were constructed using a genome editing method pCasPA/pACRISPR by combining the CRISPR/Cas9 and the phage &#x03BB;-Red recombination systems (<xref ref-type="bibr" rid="B5">Chen et al., 2018</xref>). All plasmids were constructed using ClonExpress II One Step Cloning Kit (Vazyme).</p>
</sec>
<sec id="S4.SS8">
<title>Quantitative real time-PCR</title>
<p>RNA was extracted in accordance with the aforementioned methodology. Following the isolation of total RNA, cDNA was synthesized from the extracted RNA using an RNA reverse transcription kit. cDNA was then quantified by fluorescence using a real-time fluorescence quantitative PCR kit. In this study, 16S rRNA was utilized as a reference, and the 2<sup>&#x2013;&#x0394;&#x0394;Ct</sup> value was calculated to indicate the relevant expression of the gene under investigation. The data were analyzed using GraphPad software. The primers utilized for the detection of all genes via qRT-PCR are enumerated in <xref ref-type="supplementary-material" rid="DS1">Supplementary Table 1</xref>.</p>
</sec>
<sec id="S4.SS9">
<title>Twitching motility and bacterial inert surface adhesion test</title>
<p>This experiment was conducted in accordance with the methodology proposed by <xref ref-type="bibr" rid="B6">de Bentzmann et al. (2006)</xref>. The procedure was as follows: 1. A single colony was selected from the plate of the activated strain, stabbed into the bottom of a 3 mm thick 1% LB agar plate, and incubated at 37&#x00B0;C for 16 h. The agar in the plate was then carefully taken out and stained with 1% crystal violet for 5 min. After washing away the excess dye, a clear twitching zone was visible, and the twitching motility of the strain was detected by measuring its diameter. The data for each isolation is derived from three independent biological replicate experiments.</p>
<p>For bacterial inert surface adhesion test, we employed the methodology proposed by <xref ref-type="bibr" rid="B2">Bieber et al. (1998)</xref>. The procedure is as follows: select a monoclonal colony from the plate and inoculate it in 5 mL of LB liquid medium for an overnight incubation period. Next, 400 &#x03BC;L of LB liquid medium is to be added to a sterile polystyrene 24-well plate. The overnight bacteria are then transferred into the 24-well plate at a ratio of 1:100, and the plate is left at 37&#x00B0;C for an overnight culture. The bacterial fluid in the wells should be carefully aspirated and 400 &#x03BC;L of 1% crystal violet dye should be added for a period of 5 min. The excess dye should be removed by suction, followed by the addition of 400 &#x03BC;L of 95% ethanol. The solution should then be shaken thoroughly and mixed well. Subsequently, the ethanol should be aspirated and 600 &#x03BC;L of deionized water should be added. The degree of bacterial adhesion to the inert surface can be quantified by measuring the absorbance at 570 nm. The data for each isolation is derived from three independent biological replicate experiments.</p>
</sec>
<sec id="S4.SS10">
<title>Ethics statement</title>
<p>The study received ethical approval from the Ethics Committee of the Ruijin Hospital, Shanghai Jiao Tong University (No. 2023-79). Informed consent was obtained from all participants. Sputum samples were collected from patients at Ruijin Hospital affiliated with Shanghai Jiao Tong University, and both the identities of the patients and their corresponding data included in the study were anonymized.</p>
</sec>
<sec id="S4.SS11">
<title>Statistical analysis</title>
<p>Data from at least three independent biological replicates are presented as mean &#x00B1; standard deviation (SD). Statistical analysis was performed using GraphPad Prism 9.0 software. Prior to comparative analysis, the normality of data distribution for each experimental group was assessed using the Shapiro-Wilk test. For comparisons between two groups: if data followed a normal distribution, an unpaired two-tailed Student&#x2019;s <italic>t</italic>-test was applied; if not, the non-parametric two-tailed Mann-Whitney U test was used. A <italic>p</italic>-value of less than 0.05 was considered statistically significant.</p>
</sec>
</sec>
</body>
<back>
<sec id="S5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The whole-genome sequencing data for the heteroresistant (HR) Pseudomonas aeruginosa isolates generated in this study have been deposited in the NCBI Sequence Read Archive (SRA) under BioProject accession number <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="PRJNA1038743">PRJNA1038743</ext-link>. The genome sequencing data for the corresponding resistant (R) subpopulations and the transcriptomic (RNA-seq) datasets have been deposited to the China National Center for Bioinformation (CNCB) under BioProject accession number <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="PRJCA055673">PRJCA055673</ext-link> (GSA: CRA037173, CRA037172). All other data supporting the findings of this study are available from the corresponding author upon reasonable request.</p>
</sec>
<sec id="S6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The study received ethical approval from the Ethics Committee of the Ruijin Hospital, Shanghai Jiao Tong University (No. 2023-79). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="S7" sec-type="author-contributions">
<title>Author contributions</title>
<p>XM: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Writing &#x2013; original draft. YC: Data curation, Formal analysis, Methodology, Resources, Software, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. CX: Formal analysis, Investigation, Methodology, Writing &#x2013; original draft. CoL: Formal analysis, Investigation, Methodology, Visualization, Writing &#x2013; original draft. LH: Formal analysis, Methodology, Writing &#x2013; review &#x0026; editing. ChL: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Resources, Software, Supervision, Validation, Writing - original draft. JN: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Resources, Software, Supervision, Validation, Writing review &#x0026; editing.</p>
</sec>
<sec id="S9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="S10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="S11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="S12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2026.1761186/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmicb.2026.1761186/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.pdf" id="DS1" mimetype="application/pdf"/>
<supplementary-material xlink:href="Image_1.pdf" id="FS1" mimetype="application/pdf"/>
<supplementary-material xlink:href="Image_2.pdf" id="FS2" mimetype="application/pdf"/>
<supplementary-material xlink:href="Image_3.pdf" id="FS3" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname> <given-names>D. I.</given-names></name> <name><surname>Nicoloff</surname> <given-names>H.</given-names></name> <name><surname>Hjort</surname> <given-names>K.</given-names></name></person-group> (<year>2019</year>). <article-title>Mechanisms and clinical relevance of bacterial heteroresistance.</article-title> <source><italic>Nat. Rev. Microbiol.</italic></source> <volume>17</volume> <fpage>479</fpage>&#x2013;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1038/s41579-019-0218-1</pub-id> <pub-id pub-id-type="pmid">31235888</pub-id></mixed-citation></ref>
<ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bieber</surname> <given-names>D.</given-names></name> <name><surname>Ramer</surname> <given-names>S. W.</given-names></name> <name><surname>Wu</surname> <given-names>C. Y.</given-names></name> <name><surname>Murray</surname> <given-names>W. J.</given-names></name> <name><surname>Tobe</surname> <given-names>T.</given-names></name> <name><surname>Fernandez</surname> <given-names>R.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic <italic>Escherichia coli</italic>.</article-title> <source><italic>Science</italic></source> <volume>280</volume> <fpage>2114</fpage>&#x2013;<lpage>2118</lpage>. <pub-id pub-id-type="doi">10.1126/science.280.5372.2114</pub-id> <pub-id pub-id-type="pmid">9641917</pub-id></mixed-citation></ref>
<ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolger</surname> <given-names>A. M.</given-names></name> <name><surname>Lohse</surname> <given-names>M.</given-names></name> <name><surname>Usadel</surname> <given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Trimmomatic: A flexible trimmer for Illumina sequence data.</article-title> <source><italic>Bioinformatics</italic></source> <volume>30</volume> <fpage>2114</fpage>&#x2013;<lpage>2120</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id> <pub-id pub-id-type="pmid">24695404</pub-id></mixed-citation></ref>
<ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botelho</surname> <given-names>J.</given-names></name> <name><surname>Grosso</surname> <given-names>F.</given-names></name> <name><surname>Peixe</surname> <given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>Antibiotic resistance in <italic>Pseudomonas aeruginosa</italic> - Mechanisms, epidemiology and evolution.</article-title> <source><italic>Drug Resist. Updat.</italic></source> <volume>44</volume>:<fpage>100640</fpage>. <pub-id pub-id-type="doi">10.1016/j.drup.2019.07.002</pub-id> <pub-id pub-id-type="pmid">31492517</pub-id></mixed-citation></ref>
<ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>W.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Pi</surname> <given-names>Y.</given-names></name> <name><surname>Gu</surname> <given-names>T.</given-names></name> <name><surname>Song</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>CRISPR/Cas9-based genome editing in <italic>Pseudomonas aeruginosa</italic> and cytidine deaminase-mediated base editing in <italic>Pseudomonas</italic> species.</article-title> <source><italic>iScience</italic></source> <volume>6</volume> <fpage>222</fpage>&#x2013;<lpage>231</lpage>. <pub-id pub-id-type="doi">10.1016/j.isci.2018.07.024</pub-id> <pub-id pub-id-type="pmid">30240613</pub-id></mixed-citation></ref>
<ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bentzmann</surname> <given-names>S.</given-names></name> <name><surname>Aurouze</surname> <given-names>M.</given-names></name> <name><surname>Ball</surname> <given-names>G.</given-names></name> <name><surname>Filloux</surname> <given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>FppA, a novel <italic>Pseudomonas aeruginosa</italic> prepilin peptidase involved in assembly of type IVb pili.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>188</volume> <fpage>4851</fpage>&#x2013;<lpage>4860</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00345-06</pub-id> <pub-id pub-id-type="pmid">16788194</pub-id></mixed-citation></ref>
<ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewachter</surname> <given-names>L.</given-names></name> <name><surname>Fauvart</surname> <given-names>M.</given-names></name> <name><surname>Michiels</surname> <given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Bacterial heterogeneity and antibiotic survival: Understanding and combatting persistence and heteroresistance.</article-title> <source><italic>Mol. Cell</italic></source> <volume>76</volume> <fpage>255</fpage>&#x2013;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2019.09.028</pub-id> <pub-id pub-id-type="pmid">31626749</pub-id></mixed-citation></ref>
<ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doijad</surname> <given-names>S. P.</given-names></name> <name><surname>Gisch</surname> <given-names>N.</given-names></name> <name><surname>Frantz</surname> <given-names>R.</given-names></name> <name><surname>Kumbhar</surname> <given-names>B. V.</given-names></name> <name><surname>Falgenhauer</surname> <given-names>J.</given-names></name> <name><surname>Imirzalioglu</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2023</year>). <article-title>Resolving colistin resistance and heteroresistance in <italic>Enterobacter</italic> species.</article-title> <source><italic>Nat. Commun.</italic></source> <volume>14</volume>:<fpage>140</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-022-35717-0</pub-id> <pub-id pub-id-type="pmid">36627272</pub-id></mixed-citation></ref>
<ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egge</surname> <given-names>S. L.</given-names></name> <name><surname>Rizvi</surname> <given-names>S. A.</given-names></name> <name><surname>Simar</surname> <given-names>S. R.</given-names></name> <name><surname>Alcalde</surname> <given-names>M.</given-names></name> <name><surname>Martinez</surname> <given-names>J. R. W.</given-names></name> <name><surname>Hanson</surname> <given-names>B. M.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in <italic>Pseudomonas aeruginosa</italic> of clinical origin.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>68</volume>:<fpage>e0012724</fpage>. <pub-id pub-id-type="doi">10.1128/aac.00127-24</pub-id> <pub-id pub-id-type="pmid">38995033</pub-id></mixed-citation></ref>
<ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>J.</given-names></name> <name><surname>Jia</surname> <given-names>X.</given-names></name> <name><surname>Yang</surname> <given-names>S.</given-names></name> <name><surname>Xu</surname> <given-names>X.</given-names></name> <name><surname>Sun</surname> <given-names>K.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Heteroresistance to carbapenems in invasive <italic>Pseudomonas aeruginosa</italic> infections.</article-title> <source><italic>Int. J. Antimicrob. Agents</italic></source> <volume>51</volume> <fpage>413</fpage>&#x2013;<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2017.10.014</pub-id> <pub-id pub-id-type="pmid">29127047</pub-id></mixed-citation></ref>
<ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname> <given-names>C. L.</given-names></name> <name><surname>Anderson</surname> <given-names>M. T.</given-names></name> <name><surname>Mobley</surname> <given-names>H. L. T.</given-names></name> <name><surname>Bachman</surname> <given-names>M. A.</given-names></name></person-group> (<year>2021</year>). <article-title>Pathogenesis of gram-negative bacteremia.</article-title> <source><italic>Clin. Microbiol. Rev.</italic></source> <volume>34</volume>:<fpage>e00234-20</fpage>. <pub-id pub-id-type="doi">10.1128/CMR.00234-20</pub-id> <pub-id pub-id-type="pmid">33692149</pub-id></mixed-citation></ref>
<ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard-Anderson</surname> <given-names>J.</given-names></name> <name><surname>Davis</surname> <given-names>M.</given-names></name> <name><surname>Page</surname> <given-names>A. M.</given-names></name> <name><surname>Bower</surname> <given-names>C. W.</given-names></name> <name><surname>Smith</surname> <given-names>G.</given-names></name> <name><surname>Jacob</surname> <given-names>J. T.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Prevalence of colistin heteroresistance in carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> and association with clinical outcomes in patients: An observational study.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>77</volume> <fpage>793</fpage>&#x2013;<lpage>798</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkab461</pub-id> <pub-id pub-id-type="pmid">34918135</pub-id></mixed-citation></ref>
<ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname> <given-names>X.</given-names></name> <name><surname>Ma</surname> <given-names>W.</given-names></name> <name><surname>He</surname> <given-names>J.</given-names></name> <name><surname>Tian</surname> <given-names>X.</given-names></name> <name><surname>Liu</surname> <given-names>H.</given-names></name> <name><surname>Zou</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Heteroresistance to cefepime in <italic>Pseudomonas aeruginosa</italic> bacteraemia.</article-title> <source><italic>Int. J. Antimicrob. Agents</italic></source> <volume>55</volume>:<fpage>105832</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2019.10.013</pub-id> <pub-id pub-id-type="pmid">31669739</pub-id></mixed-citation></ref>
<ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>Y.</given-names></name> <name><surname>Yang</surname> <given-names>H.</given-names></name> <name><surname>Qiao</surname> <given-names>M.</given-names></name> <name><surname>Jin</surname> <given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>MexT regulates the type III secretion system through MexS and PtrC in <italic>Pseudomonas aeruginosa</italic>.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>193</volume> <fpage>399</fpage>&#x2013;<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01079-10</pub-id> <pub-id pub-id-type="pmid">21075931</pub-id></mixed-citation></ref>
<ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>K. N.</given-names></name> <name><surname>Klein</surname> <given-names>D. R.</given-names></name> <name><surname>Kazi</surname> <given-names>M. I.</given-names></name> <name><surname>Gu&#x00E9;rin</surname> <given-names>F.</given-names></name> <name><surname>Cattoir</surname> <given-names>V.</given-names></name> <name><surname>Brodbelt</surname> <given-names>J. S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Colistin heteroresistance in <italic>Enterobacter cloacae</italic> is regulated by PhoPQ-dependent 4-amino-4-deoxy-l-arabinose addition to lipid A.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>111</volume> <fpage>1604</fpage>&#x2013;<lpage>1616</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.14240</pub-id> <pub-id pub-id-type="pmid">30873646</pub-id></mixed-citation></ref>
<ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>D.</given-names></name> <name><surname>Langmead</surname> <given-names>B.</given-names></name> <name><surname>Salzberg</surname> <given-names>S. L.</given-names></name></person-group> (<year>2015</year>). <article-title>HISAT: A fast spliced aligner with low memory requirements.</article-title> <source><italic>Nat. Methods</italic></source> <volume>12</volume> <fpage>357</fpage>&#x2013;<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.3317</pub-id> <pub-id pub-id-type="pmid">25751142</pub-id></mixed-citation></ref>
<ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krell</surname> <given-names>T.</given-names></name> <name><surname>Matilla</surname> <given-names>M. A.</given-names></name></person-group> (<year>2024</year>). <article-title>Pseudomonas aeruginosa.</article-title> <source><italic>Trends Microbiol.</italic></source> <volume>32</volume> <fpage>216</fpage>&#x2013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2023.11.005</pub-id> <pub-id pub-id-type="pmid">38065787</pub-id></mixed-citation></ref>
<ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM.</article-title> <source><italic>ArXiv [Preprint]</italic></source> <pub-id pub-id-type="doi">10.48550/arXiv.1303.3997</pub-id></mixed-citation></ref>
<ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>W. R.</given-names></name> <name><surname>Zhang</surname> <given-names>Z. Q.</given-names></name> <name><surname>Liao</surname> <given-names>K.</given-names></name> <name><surname>Wang</surname> <given-names>B. B.</given-names></name> <name><surname>Liu</surname> <given-names>H. Z.</given-names></name> <name><surname>Shi</surname> <given-names>Q. S.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title><italic>Pseudomonas aeruginosa</italic> heteroresistance to levofloxacin caused by upregulated expression of essential genes for DNA replication and repair.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>13</volume>:<fpage>1105921</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2022.1105921</pub-id> <pub-id pub-id-type="pmid">36620018</pub-id></mixed-citation></ref>
<ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>Y.</given-names></name> <name><surname>Smyth</surname> <given-names>G. K.</given-names></name> <name><surname>Shi</surname> <given-names>W.</given-names></name></person-group> (<year>2014</year>). <article-title>featureCounts: An efficient general purpose program for assigning sequence reads to genomic features.</article-title> <source><italic>Bioinformatics</italic></source> <volume>30</volume> <fpage>923</fpage>&#x2013;<lpage>930</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id> <pub-id pub-id-type="pmid">24227677</pub-id></mixed-citation></ref>
<ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>M. I.</given-names></name> <name><surname>Huber</surname> <given-names>W.</given-names></name> <name><surname>Anders</surname> <given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.</article-title> <source><italic>Genome Biol.</italic></source> <volume>15</volume>:<fpage>550</fpage>. <pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id> <pub-id pub-id-type="pmid">25516281</pub-id></mixed-citation></ref>
<ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Zhou</surname> <given-names>C.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Long</surname> <given-names>Y.</given-names></name> <name><surname>Lin</surname> <given-names>D.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title>Quorum sensing regulates heteroresistance in <italic>Pseudomonas aeruginosa</italic>.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>13</volume>:<fpage>1017707</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2022.1017707</pub-id> <pub-id pub-id-type="pmid">36386621</pub-id></mixed-citation></ref>
<ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>Q.</given-names></name> <name><surname>Xu</surname> <given-names>L.</given-names></name> <name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Fu</surname> <given-names>H.</given-names></name> <name><surname>Xiao</surname> <given-names>T.</given-names></name> <name><surname>Yu</surname> <given-names>W.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant <italic>Klebsiella pneumoniae</italic>: A genomic, retrospective cohort study.</article-title> <source><italic>Clin. Microbiol. Infect.</italic></source> <volume>30</volume> <fpage>507</fpage>&#x2013;<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmi.2024.01.014</pub-id> <pub-id pub-id-type="pmid">38295990</pub-id></mixed-citation></ref>
<ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoloff</surname> <given-names>H.</given-names></name> <name><surname>Hjort</surname> <given-names>K.</given-names></name> <name><surname>Levin</surname> <given-names>B. R.</given-names></name> <name><surname>Andersson</surname> <given-names>D. I.</given-names></name></person-group> (<year>2019</year>). <article-title>The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification.</article-title> <source><italic>Nat. Microbiol.</italic></source> <volume>4</volume> <fpage>504</fpage>&#x2013;<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-018-0342-0</pub-id> <pub-id pub-id-type="pmid">30742072</pub-id></mixed-citation></ref>
<ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname> <given-names>Z.</given-names></name> <name><surname>Raudonis</surname> <given-names>R.</given-names></name> <name><surname>Glick</surname> <given-names>B. R.</given-names></name> <name><surname>Lin</surname> <given-names>T. J.</given-names></name> <name><surname>Cheng</surname> <given-names>Z.</given-names></name></person-group> (<year>2019</year>). <article-title>Antibiotic resistance in <italic>Pseudomonas aeruginosa</italic>: Mechanisms and alternative therapeutic strategies.</article-title> <source><italic>Biotechnol. Adv.</italic></source> <volume>37</volume> <fpage>177</fpage>&#x2013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.11.013</pub-id> <pub-id pub-id-type="pmid">30500353</pub-id></mixed-citation></ref>
<ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poplin</surname> <given-names>R.</given-names></name> <name><surname>Ruano-Rubio</surname> <given-names>V.</given-names></name> <name><surname>Depristo</surname> <given-names>M.</given-names></name> <name><surname>Fennell</surname> <given-names>T. J.</given-names></name> <name><surname>Carneiro</surname> <given-names>M. O.</given-names></name> <name><surname>Van der Auwera</surname> <given-names>G. A.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Scaling accurate genetic variant discovery to tens of thousands of samples.</article-title> <source><italic>bioRxiv [Preprint]</italic></source> <pub-id pub-id-type="doi">10.1101/201178</pub-id></mixed-citation></ref>
<ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prjibelski</surname> <given-names>A.</given-names></name> <name><surname>Antipov</surname> <given-names>D.</given-names></name> <name><surname>Meleshko</surname> <given-names>D.</given-names></name> <name><surname>Lapidus</surname> <given-names>A.</given-names></name> <name><surname>Korobeynikov</surname> <given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Using SPAdes de novo assembler.</article-title> <source><italic>Curr. Protoc. Bioinform.</italic></source> <volume>70</volume>:<fpage>e102</fpage>. <pub-id pub-id-type="doi">10.1002/cpbi.102</pub-id> <pub-id pub-id-type="pmid">32559359</pub-id></mixed-citation></ref>
<ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname> <given-names>S.</given-names></name> <name><surname>Xiao</surname> <given-names>W.</given-names></name> <name><surname>Zhou</surname> <given-names>C.</given-names></name> <name><surname>Pu</surname> <given-names>Q.</given-names></name> <name><surname>Deng</surname> <given-names>X.</given-names></name> <name><surname>Lan</surname> <given-names>L.</given-names></name><etal/></person-group> (<year>2022</year>). <article-title><italic>Pseudomonas aeruginosa</italic>: Pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics.</article-title> <source><italic>Signal Transduct Target Ther.</italic></source> <volume>7</volume>:<fpage>199</fpage>. <pub-id pub-id-type="doi">10.1038/s41392-022-01056-1</pub-id> <pub-id pub-id-type="pmid">35752612</pub-id></mixed-citation></ref>
<ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seemann</surname> <given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Prokka: Rapid prokaryotic genome annotation.</article-title> <source><italic>Bioinformatics</italic></source> <volume>30</volume> <fpage>2068</fpage>&#x2013;<lpage>2069</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu153</pub-id> <pub-id pub-id-type="pmid">24642063</pub-id></mixed-citation></ref>
<ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherman</surname> <given-names>E. X.</given-names></name> <name><surname>Wozniak</surname> <given-names>J. E.</given-names></name> <name><surname>Weiss</surname> <given-names>D. S.</given-names></name></person-group> (<year>2019</year>). <article-title>Methods to evaluate colistin heteroresistance in <italic>Acinetobacter baumannii</italic>.</article-title> <source><italic>Methods Mol. Biol.</italic></source> <volume>1946</volume> <fpage>39</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-9118-1_4</pub-id> <pub-id pub-id-type="pmid">30798542</pub-id></mixed-citation></ref>
<ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobel</surname> <given-names>M. L.</given-names></name> <name><surname>Neshat</surname> <given-names>S.</given-names></name> <name><surname>Poole</surname> <given-names>K.</given-names></name></person-group> (<year>2005</year>). <article-title>Mutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of <italic>Pseudomonas aeruginosa</italic>.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>187</volume> <fpage>1246</fpage>&#x2013;<lpage>1253</lpage>. <pub-id pub-id-type="doi">10.1128/JB.187.4.1246-1253.2005</pub-id> <pub-id pub-id-type="pmid">15687188</pub-id></mixed-citation></ref>
<ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>L.</given-names></name> <name><surname>Zhou</surname> <given-names>X.</given-names></name> <name><surname>Lu</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Jiang</surname> <given-names>J.</given-names></name> <name><surname>Sun</surname> <given-names>Z.</given-names></name><etal/></person-group> (<year>2024</year>). <article-title>Levofloxacin-induced MexS mutation triggers imipenem-relebactam resistance in a KPC-producing <italic>Pseudomonas aeruginosa</italic>.</article-title> <source><italic>Int. J. Antimicrob. Agents</italic></source> <volume>63</volume>:<fpage>107119</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2024.107119</pub-id> <pub-id pub-id-type="pmid">38417706</pub-id></mixed-citation></ref>
<ref id="B33"><mixed-citation publication-type="book"><collab>World Health Organization [WHO]</collab> (<year>2024</year>). <source><italic>Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance[M/OL].</italic></source> <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>.</mixed-citation></ref>
<ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>C.</given-names></name> <name><surname>Liu</surname> <given-names>H.</given-names></name> <name><surname>Pan</surname> <given-names>X.</given-names></name> <name><surname>Ma</surname> <given-names>Z.</given-names></name> <name><surname>Wang</surname> <given-names>D.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Mechanisms for development of ciprofloxacin resistance in a clinical isolate of <italic>Pseudomonas aeruginosa</italic>.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>11</volume>:<fpage>598291</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2020.598291</pub-id> <pub-id pub-id-type="pmid">33488544</pub-id></mixed-citation></ref>
<ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>Y.</given-names></name> <name><surname>Zheng</surname> <given-names>X.</given-names></name> <name><surname>Zeng</surname> <given-names>W.</given-names></name> <name><surname>Chen</surname> <given-names>T.</given-names></name> <name><surname>Liao</surname> <given-names>W.</given-names></name> <name><surname>Qian</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Mechanisms of heteroresistance and resistance to imipenem in <italic>Pseudomonas aeruginosa</italic>.</article-title> <source><italic>Infect. Drug Resist.</italic></source> <volume>13</volume> <fpage>1419</fpage>&#x2013;<lpage>1428</lpage>. <pub-id pub-id-type="doi">10.2147/IDR.S249475</pub-id> <pub-id pub-id-type="pmid">32523360</pub-id></mixed-citation></ref>
</ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by"><p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1022072/overview">Jun Xu</ext-link>, University of the Ryukyus, Japan</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by"><p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/433404/overview">Saswat S. Mohapatra</ext-link>, Berhampur University, India</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/480697/overview">Wen-Ru Li</ext-link>, Guangdong Academy of Science, China</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/886804/overview">Vishma Pratap Sur</ext-link>, Polish Academy of Sciences, Poland</p></fn>
</fn-group>
</back>
</article>